ICON Long Term Debt 2011-2025 | ICLR

ICON long term debt from 2011 to 2025. Long term debt can be defined as the sum of all long term debt fields.
  • ICON long term debt for the quarter ending September 30, 2025 was $2.879B, a 15.4% decline year-over-year.
  • ICON long term debt for 2024 was $3.396B, a 7.34% decline from 2023.
  • ICON long term debt for 2023 was $3.665B, a 20.3% decline from 2022.
  • ICON long term debt for 2022 was $4.599B, a 14.53% decline from 2021.
ICON Annual Long Term Debt
(Millions of US $)
2024 $3,396
2023 $3,665
2022 $4,599
2021 $5,381
2020 $348
2019
2018 $349
2017 $349
2016 $349
2015 $348
2014
2013
2012
2011
2010
ICON Quarterly Long Term Debt
(Millions of US $)
2025-09-30 $2,879
2025-06-30 $3,384
2025-03-31 $3,390
2024-12-31 $3,396
2024-09-30 $3,402
2024-06-30 $3,408
2024-03-31 $3,420
2023-12-31 $3,665
2023-09-30 $3,912
2023-06-30 $4,207
2023-03-31 $4,354
2022-12-31 $4,599
2022-09-30 $4,795
2022-06-30 $4,991
2022-03-31 $5,087
2021-12-31 $5,381
2021-09-30 $5,873
2021-06-30 $350
2021-03-31 $349
2020-12-31 $348
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30 $350
2019-06-30 $349
2019-03-31 $349
2018-12-31 $349
2018-09-30 $349
2018-06-30 $349
2018-03-31 $349
2017-12-31 $349
2017-09-30 $349
2017-06-30 $349
2017-03-31 $349
2016-12-31 $349
2016-09-30 $401
2016-06-30 $348
2016-03-31 $348
2015-12-31 $348
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $12.852B $8.282B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $148.291B 27.23
HCA Healthcare (HCA) United States $108.759B 18.01
CVS Health (CVS) United States $100.272B 11.53
Elevance Health (ELV) United States $70.623B 10.36
Cencora (COR) United States $69.932B 22.56
Natera (NTRA) United States $27.391B 0.00
DiDi Global (DIDIY) China $25.980B 21.23
Labcorp Holdings (LH) United States $20.950B 15.98
Medpace Holdings (MEDP) United States $16.595B 41.20
BioMerieux (BMXMF) France $15.266B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.557B 0.00
Solventum (SOLV) United States $12.405B 12.04
CochLear (CHEOY) Australia $12.093B 0.00
Viatris (VTRS) United States $11.656B 4.34
Revvity (RVTY) United States $10.292B 18.95
Charles River Laboratories (CRL) United States $8.271B 15.93
HealthEquity (HQY) United States $8.074B 32.31
Avantor (AVTR) United States $7.875B 12.03
Caris Life Sciences,�Inc (CAI) United States $7.226B 0.00
Sonic Healthcare (SKHHY) Australia $6.746B 0.00
BrightSpring Health Services (BTSG) United States $5.977B 35.63
Bausch + Lomb (BLCO) Canada $5.508B 36.16
Sotera Health (SHC) United States $4.455B 21.48
Amplifon S.p.A (AMFPF) Italy $4.059B 23.68
GeneDx Holdings (WGS) United States $4.039B 70.93
Alignment Healthcare (ALHC) United States $3.268B 0.00
Surgery Partners (SGRY) United States $2.757B 34.68
Concentras Parent (CON) United States $2.479B 15.47
Premier (PINC) United States $2.324B 22.52
Ardent Health (ARDT) United States $2.061B 7.96
Progyny (PGNY) United States $1.923B 37.92
Pediatrix Medical (MD) United States $1.883B 11.25
Establishment Labs Holdings (ESTA) $1.883B 0.00
PACS (PACS) United States $1.878B 0.00
Organon (OGN) United States $1.763B 1.92
Teladoc Health (TDOC) United States $1.336B 0.00
Omada Health (OMDA) $1.169B 0.00
GoodRx Holdings (GDRX) United States $1.081B 17.28
Embecta (EMBC) United States $0.807B 4.72
CareDx (CDNA) United States $0.803B 13.13
InnovAge Holding (INNV) United States $0.718B 0.00
AMN Healthcare Services Inc (AMN) United States $0.685B 9.45
Nutex Health (NUTX) United States $0.637B 9.64
Sonida Senior Living (SNDA) United States $0.604B 0.00
Pomdoctor - (POM) China $0.540B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.523B 0.00
So-Young (SY) China $0.449B 0.00
CryoPort (CYRX) United States $0.420B 0.00
Enhabit (EHAB) United States $0.402B 18.07
Auna S.A (AUNA) Luxembourg $0.401B 6.02
Charming Medical (MCTA) $0.374B 0.00
Strata Critical Medical (SRTA) United States $0.362B 0.00
KindlyMD (NAKA) United States $0.339B 0.00
Oncology Institute (TOI) United States $0.331B 0.00
SBC Medicals (SBC) United States $0.327B 7.16
Agilon Health (AGL) United States $0.277B 0.00
LifeMD (LFMD) United States $0.248B 0.00
Shoulder Innovations (SI) United States $0.225B 0.00
Beauty Health (SKIN) United States $0.178B 0.00
QDM (QDMI) Hong Kong, SAR China $0.157B 26.99
Ascend Wellness Holdings (AAWH) United States $0.124B 0.00
DocGo (DCGO) United States $0.109B 0.00
Sera Prognostics (SERA) United States $0.095B 0.00
Biodesix (BDSX) United States $0.062B 0.00
IceCure Medical (ICCM) Israel $0.047B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
Basel Medical Group (BMGL) Singapore $0.026B 0.00
Synergy CHC (SNYR) United States $0.021B 5.89
Co-Diagnostics (CODX) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.017B 0.00
OSR Holdings (OSRH) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
ISpecimen (ISPC) United States $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
Pheton Holdings (PTHL) China $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00